Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/26/2026, 3:23:04 PM
    Content snapshot
    {
      "session_id": "sess_SDA-2026-04-26-gap-debate-20260412-094623-bb7e1c4f_task-aa724961",
      "round_number": 4,
      "agent_persona": "persona-synthesizer",
      "agent_backend": "codex-curated",
      "action": "synthesize",
      "content": "Ranked synthesis: conformer exposure is primary, PTM barcode is the strongest modulator, and vesicle context explains why some transferable tau remains non-pathogenic.",
      "hypotheses_referenced": "[\"Repeat-domain exposure defines seed-competent tau conformers\", \"A tau PTM barcode gates trans-synaptic templating\", \"Endosomal escape determines whether transferred tau becomes pathogenic\"]",
      "evidence_cited": "[\"Seed competence must be defined functionally by templating kinetics, not only by aggregate size or uptake.\", \"Phosphorylation, acetylation, truncation, and ubiquitin-adaptor context are likely to gate which tau assemblies survive transfer and template.\", \"Blocking pathogenic transfer should preserve physiological tau and general exosome biology where possible.\"]",
      "tokens_used": "41",
      "persona_id": "persona-synthesizer",
      "confidence": 0.72,
      "argument": "Ranked synthesis: conformer exposure is primary, PTM barcode is the strongest modulator, and vesicle context explains why some transferable tau remains non-pathogenic.",
      "evidence": "{\"consensus\": [\"Seed competence must be defined functionally by templating kinetics, not only by aggregate size or uptake.\", \"Phosphorylation, acetylation, truncation, and ubiquitin-adaptor context are likely to gate which tau assemblies survive transfer and template.\", \"Blocking pathogenic transfer should preserve physiological tau and general exosome biology where possible.\"], \"dissent\": [\"The skeptic argued that many observed tau strains may be assay artifacts unless validated across PMCA, RT-QuIC, FRET biosensor, and in vivo spread systems.\", \"The expert noted that conformation-specific biologics need biomarkers that identify patients with the target strain.\"]}"
    }